62,151 Shares in Intuitive Surgical (ISRG) Purchased by KAMES CAPITAL plc

KAMES CAPITAL plc acquired a new position in shares of Intuitive Surgical (NASDAQ:ISRG) in the first quarter, according to the company in its most recent filing with the SEC. The firm acquired 62,151 shares of the medical equipment provider’s stock, valued at approximately $25,658,000. KAMES CAPITAL plc owned approximately 0.05% of Intuitive Surgical at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Chevy Chase Trust Holdings Inc. boosted its stake in Intuitive Surgical by 206.2% in the 4th quarter. Chevy Chase Trust Holdings Inc. now owns 179,792 shares of the medical equipment provider’s stock worth $65,613,000 after buying an additional 121,082 shares during the last quarter. Atria Investments LLC boosted its stake in Intuitive Surgical by 189.4% in the 4th quarter. Atria Investments LLC now owns 1,777 shares of the medical equipment provider’s stock worth $648,000 after buying an additional 1,163 shares during the last quarter. Shaker Investments LLC OH boosted its stake in Intuitive Surgical by 200.0% in the 4th quarter. Shaker Investments LLC OH now owns 2,100 shares of the medical equipment provider’s stock worth $766,000 after buying an additional 1,400 shares during the last quarter. LPL Financial LLC boosted its stake in Intuitive Surgical by 309.0% in the 4th quarter. LPL Financial LLC now owns 16,124 shares of the medical equipment provider’s stock worth $5,884,000 after buying an additional 12,182 shares during the last quarter. Finally, Castleark Management LLC boosted its stake in Intuitive Surgical by 198.3% in the 4th quarter. Castleark Management LLC now owns 21,180 shares of the medical equipment provider’s stock worth $7,729,000 after buying an additional 14,080 shares during the last quarter. Hedge funds and other institutional investors own 87.70% of the company’s stock.

ISRG has been the topic of a number of research analyst reports. Zacks Investment Research raised Intuitive Surgical from a “hold” rating to a “buy” rating and set a $488.00 price target on the stock in a research note on Tuesday, March 20th. Morgan Stanley raised their price target on Intuitive Surgical from $450.00 to $500.00 and gave the stock an “overweight” rating in a research note on Friday, January 26th. Vetr lowered Intuitive Surgical from a “strong-buy” rating to a “buy” rating and set a $454.14 price target on the stock. in a research note on Tuesday, April 10th. Citigroup decreased their price target on Intuitive Surgical to $507.00 and set a “buy” rating on the stock in a research note on Tuesday, February 6th. Finally, Canaccord Genuity reissued a “hold” rating and issued a $410.00 price target (up from $380.00) on shares of Intuitive Surgical in a research note on Friday, January 26th. They noted that the move was a valuation call. Five equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $457.59.

NASDAQ ISRG opened at $458.79 on Friday. The stock has a market capitalization of $51.98 billion, a PE ratio of 63.81, a PEG ratio of 4.29 and a beta of 0.56. Intuitive Surgical has a 1-year low of $286.78 and a 1-year high of $473.79.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, April 17th. The medical equipment provider reported $2.44 earnings per share for the quarter, beating the consensus estimate of $2.07 by $0.37. The business had revenue of $848.00 million for the quarter, compared to analyst estimates of $773.20 million. Intuitive Surgical had a return on equity of 20.72% and a net margin of 23.25%. The company’s revenue was up 25.8% compared to the same quarter last year. During the same period in the previous year, the company posted $5.09 EPS. sell-side analysts anticipate that Intuitive Surgical will post 8.84 earnings per share for the current fiscal year.

In related news, VP Jamie Samath sold 861 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $420.09, for a total transaction of $361,697.49. Following the sale, the vice president now directly owns 1,232 shares in the company, valued at approximately $517,550.88. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Lonnie M. Smith sold 265 shares of the firm’s stock in a transaction dated Monday, May 14th. The shares were sold at an average price of $465.13, for a total value of $123,259.45. Following the sale, the director now owns 466,470 shares in the company, valued at $216,969,191.10. The disclosure for this sale can be found here. Insiders sold a total of 196,777 shares of company stock worth $88,442,993 over the last ninety days. Corporate insiders own 2.20% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical (NASDAQ:ISRG).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.




Leave a Reply